SCREENER.

IN

ALEMBIC PHARMACEUTICALS LTD

Narration
Sales
Expenses
Operating Profit
Other Income
Depreciation
Interest
Profit before tax
Tax
Net profit
EPS
Price to earning
Price
RATIOS:
Dividend Payout
OPM

Dec-99

Dec-99

Dec-99

Dec-99

Mar-11

Mar-12

Mar-13

Mar-14

Mar-15

Mar-16

Trailing
-

#VALUE!
-

#VALUE!
-

#VALUE!
-

#VALUE!
-

0.00%
#VALUE!

0.00%
#VALUE!

0.00%
#VALUE!

0.00%
#VALUE!

1,041.81
#VALUE!
3.78

#VALUE!
-

22.08%
#VALUE!

1,245.99
#VALUE!
12.76

1,268.39
#VALUE!
3.93

1,505.50
#VALUE!
3.78

1,653.17
#VALUE!
4.33

2,142.73
#VALUE!
6.10

#VALUE!
#VALUE!
54.98

#VALUE!
#VALUE!
112.80

#VALUE!
#VALUE!
282.89

#VALUE!
#VALUE!
475.33

#VALUE!
#VALUE!
587.66

#VALUE!
#VALUE!
635.15

20.28%
#VALUE!

28.52%
#VALUE!

24.82%
#VALUE!

23.32%
#VALUE!

0.00%
#VALUE!

#VALUE!

10 YEARS
#VALUE!

7 YEARS
#VALUE!

5 YEARS
#VALUE!

3 YEARS
#VALUE!

TRENDS:
Sales Growth
OPM
Price to Earning

RECENT
#VALUE!
#VALUE!

Best Case
Worst Case
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
#VALUE!
-

#VALUE!
#VALUE!
#VALUE!
#VALUE!

#VALUE!
#VALUE!
#VALUE!
#VALUE!

#VALUE!

#VALUE!

BEST
#VALUE!

WORST
#VALUE!

ALEMBIC PHARMACEUTICALS LTD

Narration
Sales
Expenses
Operating Profit
Other Income
Depreciation
Interest
Profit before tax
Tax
Net profit
OPM

Mar-14

91.29
2.77

#VALUE!

SCREENER.IN
Jun-14

96.02
0.18

#VALUE!

Sep-14

Dec-14

107.43
0.14

101.57
0.13

#VALUE!

#VALUE!

Mar-15

97.95
1.85

#VALUE!

Jun-15

Sep-15

Dec-15

Mar-16

Jun-16

104.32
0.03

376.03
0.05

384.60
2.80

142.65
2.62

156.96
0.39

#VALUE!

#VALUE!

#VALUE!

#VALUE!

#VALUE!

ALEMBIC PHARMACEUTICALS LTD

Narration
Equity Share Capital
Reserves
Borrowings
Other Liabilities
Total
Net Block
Capital Work in Progress
Investments
Other Assets
Total

SCREENER.IN

Dec-99

Dec-99

Dec-99

Dec-99

Mar-11

Mar-12

Mar-13

Mar-14

Mar-15

Mar-16

271.99

267.82

344.22

396.96

546.87

774.78

Working Capital
Debtors
Inventory

#VALUE!
-

#VALUE!
-

#VALUE!
-

#VALUE!
-

#VALUE!
201.97

#VALUE!
199.33

#VALUE!
232.87

#VALUE!
273.37

#VALUE!
361.17

#VALUE!
350.48

Debtor Days
Inventory Turnover

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!
#VALUE!

#VALUE!

#VALUE!

#VALUE!

#VALUE!

#VALUE!

#VALUE!

#VALUE!

#VALUE!

#VALUE!

#VALUE!

Return on Equity
Return on Capital Emp

ALEMBIC PHARMACEUTICALS LTD

Narration
Cash from Operating Activity
Cash from Investing Activity
Cash from Financing Activity
Net Cash Flow

SCREENER.IN
Dec-99

Dec-99

Dec-99

Dec-99

Mar-11

Mar-12

Mar-13

Mar-14

Mar-15

Mar-16

How to use it?

You can customize this workbook as you want.

You can add custom formating, add conditional formating, add your own formulas do AN
Please don't edit the "Data Sheet" only.
After customization, you can upload this back on Screener.
Upload on:
https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at:

screener.feedback@dala

our own formulas do ANYTHING.

xport your customized file.

creener.feedback@dalal-street.in

COMPANY NAME
LATEST VERSION
CURRENT VERSION
META
Number of shares
Face Value
Current Price
Market Capitalization

ALEMBIC PHARMACEUTICALS LTD

2.10
2.10

18.85
2
635.15
11972.58

PROFIT & LOSS

Report Date
Sales
Raw Material Cost
Change in Inventory
Power and Fuel
Other Mfr. Exp
Employee Cost
Selling and admin
Other Expenses
Other Income
Depreciation
Interest
Profit before tax
Tax
Net profit
Dividend Amount

Quarters
Report Date
Sales
Expenses
Other Income
Depreciation
Interest
Profit before tax
Tax

Mar-14
464.03
372.74
2.77
10.99
2.29
80.78
19.49

Jun-14
494.28
398.26
0.18
10.71
0.56
84.93
20.28

Sep-14
547.08
439.65
0.14
10.84
1.04
95.69
18.43

Net profit
Operating Profit

61.29
91.29

64.67
96.02

77.27
107.43

BALANCE SHEET
Report Date
Equity Share Capital
Reserves
Borrowings
Other Liabilities
Total
Net Block
Capital Work in Progress
Investments
Other Assets
Total
Receivables
Inventory
Cash & Bank
No. of Equity Shares
New Bonus Shares
Face value

CASH FLOW:
Report Date
Cash from Operating Activity
Cash from Investing Activity
Cash from Financing Activity
Net Cash Flow

PRICE:
DERIVED:
Adjusted Equity Shares in Cr

PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Dec-14
511.78
410.21
0.13
11.90
-0.18
89.98
19.33

Mar-11
1,202.05
595.13
4.72
24.58
35.24
149.21
223.80
18.57
3.78
29.59
27.59
106.84
21.45
85.39
18.85

Mar-12
1,465.41
772.36
64.44
29.57
54.72
168.46
268.79
16.53
12.76
33.65
37.55
160.98
30.85
130.13
26.39

Mar-13
1,520.35
659.36
-21.34
26.66
46.52
193.79
316.82
3.90
3.93
34.97
14.57
206.35
41.10
165.25
47.13

Mar-14
1,863.22
754.00
40.65
32.07
69.67
247.00
428.20
15.21
3.78
40.49
10.40
310.61
75.10
235.51
58.45

Mar-15
502.98
405.03
1.85
10.96
0.36
88.48
18.31

Jun-15
582.55
478.23
0.03
12.89
0.62
90.84
19.17

Sep-15
1,008.76
632.73
0.05
13.27
0.73
362.08
73.54

Dec-15
924.50
539.90
2.80
21.65
1.04
364.71
95.11

70.66
101.57

70.33
97.95

Mar-11

Mar-12

288.90
376.03

Mar-13

269.49
384.6

Mar-14

11
259.03
327.91
270.08
868.02
271.99
26.5
3.26
566.27
868.02
201.97
219.23
6.29
55000000

37.7
357.29
352.72
323.69
1,071.40
267.82
58.24
3.3
742.04
1,071.40
199.33
258.74
47.09
188515914

37.7
465.24
186.8
374.65
1,064.39
344.22
32.26
3.3
684.61
1,064.39
232.87
266.83
16.11
188515914

37.7
637.87
109.4
448.61
1,233.58
396.96
20.67
3.36
812.59
1,233.58
273.37
310.78
23.96
188515914

Mar-11
94.99
-56.82
-46.95
-8.78

71.73
104.32

5.50

Mar-12
141.77
-56.39
-44.58
40.80

Mar-13
264.82
-67.02
-228.78
-30.98

Mar-14
239.97
-81.06
-151.05
7.86

54.98

112.80

282.89

18.85

18.85

18.85

THIS SHEET

Mar-15
2,056.13
787.42
72.89
43.31
67.07
306.76
511.99
9.51
4.33
44.41
3.81
359.07
76.35
282.92
65.98

Mar-16
3,148.71
865.36
95.94
50.69
100.88
421.38
757.27
43.09
6.10
72.21
4.27
935.61
216.01
719.44

Mar-16
617.97
475.32
2.62
24.40
1.30
119.57
27.76

Jun-16
728.04
571.08
0.39
19.38
1.07
136.90
33.27

91.36
142.65

Mar-15

103.75
156.96

Mar-16

37.7
846.94
263.5
509.27
1,657.41
546.87
83.14
2.26
1025.14
1,657.41
361.17
382.77
26.83
188515914

37.7
1562.84
132.51
742.75
2,475.80
774.78
92.52
2.11
1606.39
2,475.80
350.48
577.58
450.83
188515914

Mar-15
171.76
-255.61
86.72
2.86

Mar-16
930.39
-310.48
-195.91
424.00

475.33

587.66

18.85

18.85